>About VOHC
>Administrative Staff
>Veterinary Staff
>Technical Staff
>Our Facilities
>Clinical Trials
>FAQs
>Animal Cancer Foundation
>Contact Us
>Directions
Clinical Trials for Malignant Histiocytosis
 
Satraplatin for any tumor, including lymphoma

Eligibility Requirements
• Any tumor, including lymphoma confirmed by histopathology or cytology

Study Objective
To determine efficacy of using Satraplatin for various types of cancer using 5mg/m2 daily (orally).

Compensation
This study is partially funded. Please click on link for more details.

Location of Trial
Columbia, MO

More information

 
HOME  |  DIRECTIONS  |  CONTACT US  |  REFERRING VETS  |  SITE MAP
©2006 Veterinary Oncology & Hematology Center, LLC. Last updated 12/12/2007
Site Designed by One Brain Marketing, LLC. Hosted by Advanced Web Systems
“Smokey taught me the value of leaving no stone unturned in the search for better therapies and
the importance of hope.”
               - Dr Gerald Post
> Smokey's Story
> Other Success Stories